Skip to main content
. 2017 Jul 26;8(39):65917–65931. doi: 10.18632/oncotarget.19579

Figure 5. In vitro characteristics of 89Zr-DFO-MPA1.

Figure 5

(A) Representative radio-ITLC (instant thin layer chromatography) of 89Zr-DFO-MPA1 showing high radiochemical purity (>99%) as 89Zr-DFO-MPA1 remains at baseline and free 89Zr was undetectable (developed in 50mM DTPA). (B) Competitive binding assay of 89Zr-DFO-MPA1 in THP-1 cells indicate no significant loss of affinity during radiolabeling. Radiotracer binding gradually decreases with incremental increase of unlabeled MPA1 blocking (IC50=11.51 nM).